Fertility and Sterility
Volume 92, Issue 3 , Pages 1039-1044, September 2009

Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women

  • David F. Archer, M.D.

      Affiliations

    • CONRAD Clinical Research Center, Eastern Virginia Medical School, Norfolk, Virginia
    • Corresponding Author InformationReprint requests: David F. Archer, M.D., CONRAD Clinical Research Center, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507 (FAX: 757-446-8998).
    • ,
  • Vivian Lewis, M.D.

      Affiliations

    • University of Rochester Medical Center, Rochester, New York
    • ,
  • Bruce R. Carr, M.D.

      Affiliations

    • University of Texas Southwestern Medical Center, Dallas, Texas
    • ,
  • Sophie Olivier, M.D.

      Affiliations

    • Wyeth Research, Collegeville, Pennsylvania
    • ,
  • James H. Pickar, M.D.

      Affiliations

    • Wyeth Research, Collegeville, Pennsylvania

Received 18 September 2008; received in revised form 8 May 2009; accepted 22 May 2009. published online 27 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 D.F.A. has received research grants from and is a consultant and speaker for Wyeth. V.L. has received research grants from Wyeth. B.R.C. has served as a lecturer for Wyeth and Novo Nordisk and has received research grants from Duramed, Neurocrine, and Boehringer Ingelheim. S.O. was previously an employee of Wyeth. J.H.P. is an employee of Wyeth.

 Sponsored by Wyeth Research, Collegeville, PA.

 Portions of this work were presented at the 89th Annual Meeting of the Endocrine Society; June 2–5, 2007; Toronto, Ontario, Canada. Abstract P1-350.

 The Selective estrogen Menopause And Response to Therapy (SMART)-1 trial was a 2-year, outpatient, randomized, double-blind, placebo- and active-controlled, phase III study conducted at 94 sites in the United States, Europe, and Brazil (Unique trial number: NCT00675688; Trial registration date: 05/09/2008).

PII: S0015-0282(09)01303-X

doi:10.1016/j.fertnstert.2009.05.093

Fertility and Sterility
Volume 92, Issue 3 , Pages 1039-1044, September 2009

Article Tools

* Image Usage & Resolution